Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa

Hidradenitis suppurativa Research


Author(s): Boer J, van Gemert MJ

BACKGROUND: Oral isotretinoin has been used to treat mild to severe hidradenitis suppurativa (HS).

OBJECTIVE: We reviewed the results of low-dose isotretinoin for 4 to 6 months in the treatment of 68 patients with HS.

METHODS: This is a retrospective study. Data are presented in terms of response rate, long-term follow-up, and the relation between response rate and severity.

RESULTS: In 16 patients (23.5%), the condition completely cleared during initial therapy and 11 patients (16.2%) maintained their improvement during the follow-up period. Treatment was more successful in the milder forms of HS.

CONCLUSION: Monotherapy with isotretinoin for patients with HS usually has a limited therapeutic effect.


Dermatology Journal and/or Publisher

Journal Name: Journal of the American Academy of Dermatology
Journal Abbreviation: J. Am. Acad. Dermatol.
Journal Date Published: 1999-02-18


National Center for Biotechnology Information

PMID: 9922015
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/9922015
Lasted Revision: 2013-11-21


Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).


Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Translate »

Log in with your credentials

Forgot your details?